Matthew Frieman, Ph.D. - Publications

1998-2004 Molecular Biology and Genetics Johns Hopkins University, Baltimore, MD 
 2004-2009 Epidemiology University of North Carolina at Chapel Hill School of Medicine 
 2009- Microbiology and Immunology University of Maryland School of Medicine, Baltimore, MD, United States 
Molecular Biology, Microbiology Biology, Virology

76 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kulcsar KA, Coleman CM, Beck SE, Frieman MB. Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection. Jci Insight. PMID 31550243 DOI: 10.1172/jci.insight.131774  1
2019 Weston S, Matthews KL, Lent R, Vlk A, Haupt R, Kingsbury T, Frieman MB. A yeast suppressor screen used to identify mammalian SIRT1 as a proviral factor for MERS-CoV replication. Journal of Virology. PMID 31142674 DOI: 10.1128/JVI.00197-19  1
2019 Banerjee A, Kulcsar K, Misra V, Frieman M, Mossman K. Bats and Coronaviruses. Viruses. 11. PMID 30634396 DOI: 10.3390/v11010041  1
2018 Cong Y, Hart BJ, Gross R, Zhou H, Frieman M, Bollinger L, Wada J, Hensley LE, Jahrling PB, Dyall J, Holbrook MR. MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. Plos One. 13: e0194868. PMID 29566060 DOI: 10.1371/journal.pone.0194868  1
2018 Sisk JM, Frieman MB, Machamer CE. Coronavirus S protein-induced fusion is blocked prior to hemifusion by Abl kinase inhibitors. The Journal of General Virology. PMID 29557770 DOI: 10.1099/jgv.0.001047  1
2017 Dyall J, Gross R, Kindrachuk J, Johnson RF, Olinger GG, Hensley LE, Frieman MB, Jahrling PB. Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies. Drugs. PMID 29143192 DOI: 10.1007/s40265-017-0830-1  1
2017 Rao X, Deiuliis JA, Mihai G, Varghese J, Xia C, Frieman MB, Sztalryd C, Sun XJ, Quon MJ, Taylor SI, Rajagopalan S, Zhong J. Monocyte DPP4 Expression in Human Atherosclerosis Is Associated With Obesity and Dyslipidemia. Diabetes Care. PMID 29127241 DOI: 10.2337/dc17-0672  0.08
2017 Venkataraman T, Coleman C, Frieman M. Overactive EGFR Signaling Leads to Increased Fibrosis After SARS-CoV Infection. Journal of Virology. PMID 28404843 DOI: 10.1128/JVI.00182-17  1
2017 Venkataraman T, Frieman MB. The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis. Antiviral Research. PMID 28390872 DOI: 10.1016/j.antiviral.2017.03.022  1
2017 Coleman CM, Venkataraman T, Liu YV, Glenn GM, Smith GE, Flyer DC, Frieman MB. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection. Vaccine. PMID 28237499 DOI: 10.1016/j.vaccine.2017.02.012  1
2016 Moser LA, Ramirez-Carvajal L, Puri V, Pauszek SJ, Matthews K, Dilley KA, Mullan C, McGraw J, Khayat M, Beeri K, Yee A, Dugan V, Heise MT, Frieman MB, Rodriguez LL, et al. A Universal Next-Generation Sequencing Protocol To Generate Noninfectious Barcoded cDNA Libraries from High-Containment RNA Viruses. Msystems. 1. PMID 27822536 DOI: 10.1128/mSystems.00039-15  1
2016 Wirblich C, Coleman CM, Kurup D, Abraham TS, Bernbaum JG, Jahrling PB, Hensley LE, Johnson RF, Frieman MB, Schnell MJ. One-Health: A Safe, Efficient Dual-use Vaccine for Humans and Animals against MERS-CoV and Rabies Virus. Journal of Virology. PMID 27807241 DOI: 10.1128/JVI.02040-16  1
2016 Coleman CM, Sisk JM, Halasz G, Zhong J, Beck SE, Matthews KL, Venkataraman T, Rajagopalan S, Kyratsous CA, Frieman MB. CD8+ T cells and Macrophages Regulate Pathogenesis in a Mouse Model of MERS-CoV Disease. Journal of Virology. PMID 27795435 DOI: 10.1128/JVI.01825-16  1
2016 Coleman CM, Sisk JM, Mingo RM, Nelson EA, White JM, Frieman MB. ABL kinase inhibitors are potent inhibitors of SARS-CoV and MERS-CoV fusion. Journal of Virology. PMID 27466418 DOI: 10.1128/JVI.01429-16  1
2016 Luke T, Wu H, Zhao J, Channappanavar R, Coleman CM, Jiao JA, Matsushita H, Liu Y, Postnikova EN, Ork BL, Glenn G, Flyer D, Defang G, Raviprakash K, Kochel T, ... ... Frieman MB, et al. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo. Science Translational Medicine. 8: 326ra21. PMID 26888429 DOI: 10.1126/scitranslmed.aaf1061  1
2016 Sisk JM, Frieman MB. Screening of FDA-Approved Drugs for Treatment of Emerging Pathogens Acs Infectious Diseases. 1: 401-402. DOI: 10.1021/acsinfecdis.5b00089  1
2015 Sisk JM, Frieman MB. Screening of FDA-Approved Drugs for Treatment of Emerging Pathogens. Acs Infectious Diseases. 1: 401-2. PMID 27617922 DOI: 10.1021/acsinfecdis.5b00089  1
2015 Gralinski LE, Ferris MT, Aylor DL, Whitmore AC, Green R, Frieman MB, Deming D, Menachery VD, Miller DR, Buus RJ, Bell TA, Churchill GA, Threadgill DW, Katze MG, McMillan L, et al. Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross. Plos Genetics. 11: e1005504. PMID 26452100 DOI: 10.1371/journal.pgen.1005504  1
2015 Taylor JK, Coleman CM, Postel S, Sisk JM, Bernbaum JG, Venkataraman T, Sundberg EJ, Frieman MB. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference. Journal of Virology. 89: 11820-33. PMID 26378163 DOI: 10.1128/JVI.02274-15  1
2015 Coleman CM, Frieman MB. Growth and Quantification of MERS-CoV Infection. Current Protocols in Toxicology / Editorial Board, Mahin D. Maines (Editor-in-Chief) ... [Et Al.]. 64: 15E.2.1-9. PMID 26344222 DOI: 10.1002/9780471729259.mc15e02s37  1
2015 Coleman CM, Frieman MB. Growth and Quantification of MERS-CoV Infection. Current Protocols in Microbiology. 37: 15E.2.1-9. PMID 26344219 DOI: 10.1002/9780471729259.mc15e02s37  1
2015 Pascal KE, Coleman CM, Mujica AO, Kamat V, Badithe A, Fairhurst J, Hunt C, Strein J, Berrebi A, Sisk JM, Matthews KL, Babb R, Chen G, Lai KV, Huang TT, ... ... Frieman MB, et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 26124093 DOI: 10.1073/pnas.1510830112  1
2015 McSweegan E, Weaver SC, Lecuit M, Frieman M, Morrison TE, Hrynkow S. The Global Virus Network: Challenging chikungunya. Antiviral Research. 120: 147-52. PMID 26071007 DOI: 10.1016/j.antiviral.2015.06.003  1
2015 Frieman M, Sola I, Enjuanes L. Virus Research. Foreword. Nidoviruses II. Virus Research. 202: 1-2. PMID 26025418 DOI: 10.1016/j.virusres.2015.05.013  1
2015 Mojica SA, Hovis KM, Frieman MB, Tran B, Hsia RC, Ravel J, Jenkins-Houk C, Wilson KL, Bavoil PM. SINC, a type III secreted protein of Chlamydia psittaci, targets the inner nuclear membrane of infected cells and uninfected neighbors. Molecular Biology of the Cell. 26: 1918-34. PMID 25788290 DOI: 10.1091/mbc.E14-11-1530  0.01
2015 Astry B, Venkatesha SH, Laurence A, Christensen-Quick A, Garzino-Demo A, Frieman MB, O'Shea JJ, Moudgil KD. Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ. Clinical Immunology (Orlando, Fla.). 157: 228-38. PMID 25660987 DOI: 10.1016/j.clim.2015.01.011  1
2015 Nita-Lazar M, Banerjee A, Feng C, Amin MN, Frieman MB, Chen WH, Cross AS, Wang LX, Vasta GR. Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding. Molecular Immunology. 65: 1-16. PMID 25597246 DOI: 10.1016/j.molimm.2014.12.010  1
2015 Kindrachuk J, Ork B, Hart BJ, Mazur S, Holbrook MR, Frieman MB, Traynor D, Johnson RF, Dyall J, Kuhn JH, Olinger GG, Hensley LE, Jahrling PB. Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrobial Agents and Chemotherapy. 59: 1088-99. PMID 25487801 DOI: 10.1128/AAC.03659-14  1
2014 Enjuanes L, Sola I, Frieman MB. Virus Research. Nidoviruses I. Foreword. Virus Research. 194: 1-2. PMID 25483881 DOI: 10.1016/j.virusres.2014.11.017  1
2014 Matthews K, Schäfer A, Pham A, Frieman M. The SARS coronavirus papain like protease can inhibit IRF3 at a post activation step that requires deubiquitination activity. Virology Journal. 11: 209. PMID 25481026 DOI: 10.1186/s12985-014-0209-9  1
2014 Coleman CM, Frieman MB. Treating MERS-CoV during an outbreak. The Lancet. Infectious Diseases. 14: 1030-1. PMID 25278219 DOI: 10.1016/S1473-3099(14)70939-9  1
2014 Li J, Sun W, Subrahmanyam PB, Page C, Younger KM, Tiper IV, Frieman M, Kimball AS, Webb TJ. NKT Cell Responses to B Cell Lymphoma. Medical Sciences : Open Access Journal. 2: 82-97. PMID 24955247 DOI: 10.3390/medsci2020082  1
2014 Ladner JT, Beitzel B, Chain PS, Davenport MG, Donaldson EF, Frieman M, Kugelman JR, Kuhn JH, O'Rear J, Sabeti PC, Wentworth DE, Wiley MR, Yu GY, Sozhamannan S, et al. Standards for sequencing viral genomes in the era of high-throughput sequencing. Mbio. 5: e01360-14. PMID 24939889 DOI: 10.1128/mBio.01360-14  1
2014 Frieman M. The art of war: battles between virus and host. Current Opinion in Virology. 6: 76-7. PMID 24886699 DOI: 10.1016/j.coviro.2014.05.001  1
2014 Dyall J, Coleman CM, Hart BJ, Venkataraman T, Holbrook MR, Kindrachuk J, Johnson RF, Olinger GG, Jahrling PB, Laidlaw M, Johansen LM, Lear-Rooney CM, Glass PJ, Hensley LE, Frieman MB. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Antimicrobial Agents and Chemotherapy. 58: 4885-93. PMID 24841273 DOI: 10.1128/AAC.03036-14  1
2014 Adedeji AO, Singh K, Kassim A, Coleman CM, Elliott R, Weiss SR, Frieman MB, Sarafianos SG. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Antimicrobial Agents and Chemotherapy. 58: 4894-8. PMID 24841268 DOI: 10.1128/AAC.02994-14  1
2014 Coleman CM, Liu YV, Mu H, Taylor JK, Massare M, Flyer DC, Glenn GM, Smith GE, Frieman MB. Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice. Vaccine. 32: 3169-74. PMID 24736006 DOI: 10.1016/j.vaccine.2014.04.016  1
2014 Coleman CM, Frieman MB. Coronaviruses: important emerging human pathogens. Journal of Virology. 88: 5209-12. PMID 24600003 DOI: 10.1128/JVI.03488-13  1
2014 Matthews KL, Coleman CM, van der Meer Y, Snijder EJ, Frieman MB. The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. The Journal of General Virology. 95: 874-82. PMID 24443473 DOI: 10.1099/vir.0.062059-0  1
2014 Kim WK, Jain D, Sánchez MD, Koziol-White CJ, Matthews K, Ge MQ, Haczku A, Panettieri RA, Frieman MB, López CB. Deficiency of melanoma differentiation-associated protein 5 results in exacerbated chronic postviral lung inflammation. American Journal of Respiratory and Critical Care Medicine. 189: 437-48. PMID 24417465 DOI: 10.1164/rccm.201307-1338OC  1
2014 Hart BJ, Dyall J, Postnikova E, Zhou H, Kindrachuk J, Johnson RF, Olinger GG, Frieman MB, Holbrook MR, Jahrling PB, Hensley L. Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays. The Journal of General Virology. 95: 571-7. PMID 24323636 DOI: 10.1099/vir.0.061911-0  1
2014 Coleman CM, Matthews KL, Goicochea L, Frieman MB. Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus. The Journal of General Virology. 95: 408-12. PMID 24197535 DOI: 10.1099/vir.0.060640-0  1
2013 Coleman CM, Frieman MB. Emergence of the Middle East respiratory syndrome coronavirus. Plos Pathogens. 9: e1003595. PMID 24039577 DOI: 10.1371/journal.ppat.1003595  1
2012 Page C, Goicochea L, Matthews K, Zhang Y, Klover P, Holtzman MJ, Hennighausen L, Frieman M. Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection. Journal of Virology. 86: 13334-49. PMID 23015710 DOI: 10.1128/JVI.01689-12  1
2012 Huynh J, Li S, Yount B, Smith A, Sturges L, Olsen JC, Nagel J, Johnson JB, Agnihothram S, Gates JE, Frieman MB, Baric RS, Donaldson EF. Evidence supporting a zoonotic origin of human coronavirus strain NL63. Journal of Virology. 86: 12816-25. PMID 22993147 DOI: 10.1128/JVI.00906-12  1
2012 Frieman M, Yount B, Agnihothram S, Page C, Donaldson E, Roberts A, Vogel L, Woodruff B, Scorpio D, Subbarao K, Baric RS. Molecular determinants of severe acute respiratory syndrome coronavirus pathogenesis and virulence in young and aged mouse models of human disease. Journal of Virology. 86: 884-97. PMID 22072787 DOI: 10.1128/JVI.05957-11  1
2012 Chen WH, Toapanta FR, Shirey KA, Zhang L, Giannelou A, Page C, Frieman MB, Vogel SN, Cross AS. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. Immunology Letters. 141: 227-34. PMID 22037624 DOI: 10.1016/j.imlet.2011.10.009  1
2011 Frieman M, Basu D, Matthews K, Taylor J, Jones G, Pickles R, Baric R, Engel DA. Yeast based small molecule screen for inhibitors of SARS-CoV. Plos One. 6: e28479. PMID 22164298 DOI: 10.1371/journal.pone.0028479  1
2011 Peng X, Gralinski L, Ferris MT, Frieman MB, Thomas MJ, Proll S, Korth MJ, Tisoncik JR, Heise M, Luo S, Schroth GP, Tumpey TM, Li C, Kawaoka Y, Baric RS, et al. Integrative deep sequencing of the mouse lung transcriptome reveals differential expression of diverse classes of small RNAs in response to respiratory virus infection. Mbio. 2. PMID 22086488 DOI: 10.1128/mBio.00198-11  1
2011 Aylor DL, Valdar W, Foulds-Mathes W, Buus RJ, Verdugo RA, Baric RS, Ferris MT, Frelinger JA, Heise M, Frieman MB, Gralinski LE, Bell TA, Didion JD, Hua K, Nehrenberg DL, et al. Genetic analysis of complex traits in the emerging Collaborative Cross. Genome Research. 21: 1213-22. PMID 21406540 DOI: 10.1101/gr.111310.110  1
2010 Peng X, Gralinski L, Armour CD, Ferris MT, Thomas MJ, Proll S, Bradel-Tretheway BG, Korth MJ, Castle JC, Biery MC, Bouzek HK, Haynor DR, Frieman MB, Heise M, Raymond CK, et al. Unique signatures of long noncoding RNA expression in response to virus infection and altered innate immune signaling. Mbio. 1. PMID 20978541 DOI: 10.1128/mBio.00206-10  1
2010 Donaldson EF, Haskew AN, Gates JE, Huynh J, Moore CJ, Frieman MB. Metagenomic analysis of the viromes of three North American bat species: viral diversity among different bat species that share a common habitat. Journal of Virology. 84: 13004-18. PMID 20926577 DOI: 10.1128/JVI.01255-10  1
2010 Zornetzer GA, Frieman MB, Rosenzweig E, Korth MJ, Page C, Baric RS, Katze MG. Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection. Journal of Virology. 84: 11297-309. PMID 20702617 DOI: 10.1128/JVI.01130-10  1
2010 Frieman MB, Chen J, Morrison TE, Whitmore A, Funkhouser W, Ward JM, Lamirande EW, Roberts A, Heise M, Subbarao K, Baric RS. SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. Plos Pathogens. 6: e1000849. PMID 20386712 DOI: 10.1371/journal.ppat.1000849  1
2010 Rockx B, Donaldson E, Frieman M, Sheahan T, Corti D, Lanzavecchia A, Baric RS. Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. The Journal of Infectious Diseases. 201: 946-55. PMID 20144042 DOI: 10.1086/651022  1
2010 Freundt EC, Yu L, Goldsmith CS, Welsh S, Cheng A, Yount B, Liu W, Frieman MB, Buchholz UJ, Screaton GR, Lippincott-Schwartz J, Zaki SR, Xu XN, Baric RS, Subbarao K, et al. The open reading frame 3a protein of severe acute respiratory syndrome-associated coronavirus promotes membrane rearrangement and cell death. Journal of Virology. 84: 1097-109. PMID 19889773 DOI: 10.1128/JVI.01662-09  1
2010 Ortiz-Alcantara J, Bhardwaj K, Palaninathan S, Frieman M, Baric RS, Kao CC. Small molecule inhibitors of the SARS-CoV Nsp15 endoribonuclease Virus Adaptation and Treatment. 2: 125-133. DOI: 10.2147/VAAT.S12733  1
2009 Day CW, Baric R, Cai SX, Frieman M, Kumaki Y, Morrey JD, Smee DF, Barnard DL. A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo. Virology. 395: 210-22. PMID 19853271 DOI: 10.1016/j.virol.2009.09.023  1
2009 Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, Dyer MD, Teal TH, Proll S, van den Brand J, Baric R, Katze MG. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection. Journal of Virology. 83: 7062-74. PMID 19420084 DOI: 10.1128/JVI.00127-09  1
2009 Frieman M, Ratia K, Johnston RE, Mesecar AD, Baric RS. Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling. Journal of Virology. 83: 6689-705. PMID 19369340 DOI: 10.1128/JVI.02220-08  1
2009 Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA. Novel influenza virus NS1 antagonists block replication and restore innate immune function. Journal of Virology. 83: 1881-91. PMID 19052087 DOI: 10.1128/JVI.01805-08  1
2009 Rockx B, Baas T, Zornetzer GA, Haagmans B, Sheahan T, Frieman M, Dyer MD, Teal TH, Proll S, Van Den Brand J, Baric R, Katze MG. Early upregulation of acute respiratory distress syndrome-associated cytokines promotes lethal disease in an aged-mouse model of severe acute respiratory syndrome coronavirus infection (Journal of Virology (2009) 83, 14, (7062-7074)) Journal of Virology. 83: 9022. DOI: 10.1128/JVI.01322-09  1
2008 Frieman M, Baric R. Mechanisms of severe acute respiratory syndrome pathogenesis and innate immunomodulation. Microbiology and Molecular Biology Reviews : Mmbr. 72: 672-85, Table of Con. PMID 19052324 DOI: 10.1128/MMBR.00015-08  1
2008 Zupancic ML, Frieman M, Smith D, Alvarez RA, Cummings RD, Cormack BP. Glycan microarray analysis of Candida glabrata adhesin ligand specificity. Molecular Microbiology. 68: 547-59. PMID 18394144 DOI: 10.1111/j.1365-2958.2008.06184.x  1
2008 Frieman M, Heise M, Baric R. SARS coronavirus and innate immunity. Virus Research. 133: 101-12. PMID 17451827 DOI: 10.1016/j.virusres.2007.03.015  1
2007 Wathelet MG, Orr M, Frieman MB, Baric RS. Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain. Journal of Virology. 81: 11620-33. PMID 17715225 DOI: 10.1128/JVI.00702-07  1
2007 Frieman M, Yount B, Heise M, Kopecky-Bromberg SA, Palese P, Baric RS. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. Journal of Virology. 81: 9812-24. PMID 17596301 DOI: 10.1128/JVI.01012-07  1
2007 Kopecky-Bromberg SA, Martínez-Sobrido L, Frieman M, Baric RA, Palese P. Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. Journal of Virology. 81: 548-57. PMID 17108024 DOI: 10.1128/JVI.01782-06  1
2006 Baric RS, Sheahan T, Deming D, Donaldson E, Yount B, Sims AC, Roberts RS, Frieman M, Rockx B. SARS coronavirus vaccine development. Advances in Experimental Medicine and Biology. 581: 553-60. PMID 17037597 DOI: 10.1007/978-0-387-33012-9_101  1
2006 Frieman MB, Yount B, Sims AC, Deming DJ, Morrison TE, Sparks J, Denison M, Heise M, Baric RS. SARS coronavirus accessory ORFs encode luxury functions. Advances in Experimental Medicine and Biology. 581: 149-52. PMID 17037522 DOI: 10.1007/978-0-387-33012-9_26  1
2005 Yount B, Roberts RS, Sims AC, Deming D, Frieman MB, Sparks J, Denison MR, Davis N, Baric RS. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. Journal of Virology. 79: 14909-22. PMID 16282490 DOI: 10.1128/JVI.79.23.14909-14922.2005  1
2004 Frieman MB, Cormack BP. Multiple sequence signals determine the distribution of glycosylphosphatidylinositol proteins between the plasma membrane and cell wall in Saccharomyces cerevisiae. Microbiology (Reading, England). 150: 3105-14. PMID 15470092 DOI: 10.1099/mic.0.27420-0  1
2003 Frieman MB, Cormack BP. The omega-site sequence of glycosylphosphatidylinositol-anchored proteins in Saccharomyces cerevisiae can determine distribution between the membrane and the cell wall. Molecular Microbiology. 50: 883-96. PMID 14617149 DOI: 10.1046/j.1365-2958.2003.03722.x  1
2002 Frieman MB, McCaffery JM, Cormack BP. Modular domain structure in the Candida glabrata adhesin Epa1p, a beta1,6 glucan-cross-linked cell wall protein. Molecular Microbiology. 46: 479-92. PMID 12406223 DOI: 10.1046/j.1365-2958.2002.03166.x  1
2002 Strichman-Almashanu LZ, Lee RS, Onyango PO, Perlman E, Flam F, Frieman MB, Feinberg AP. A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. Genome Research. 12: 543-54. PMID 11932239 DOI: 10.1101/gr.224102. Article published online before print in March 2002  1
1999 Frieman M, Chen ZJ, Saez-Vasquez J, Shen LA, Pikaard CS. RNA polymerase I transcription in a Brassica interspecific hybrid and its progenitors: Tests of transcription factor involvement in nucleolar dominance. Genetics. 152: 451-60. PMID 10224274  1
Show low-probability matches.